Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11
Viatris lawsuit is the one to watch 20312033: Most analysts' baseline forecast for final FDA approval and US market launch, assuming patents run their course 20332036: More conservative estimates accounting for remaining IP layers What could change this timeline: Further successful patent challenges by generic manufacturers Congressional or executive action to accelerate generic biologics access Expanded FDA streamlining of the biosimilar approval pathway For now, the cost relief available globally in 2026 will not reach US patients through the generic or biosimilar route
How do you maintain weight loss after stopping
Keep a sugar replacement, such as fruit juice or glucose alternatives, on hand if you experience these symptoms
But consider the cost-benefit analysis honestly
Using FDA-approved therapies like tirzepatide and semaglutide with close medical supervision, patients achieve meaningful, sustained weight loss and improved metabolic health
